OM · Outset Medical, Inc.
$4.13
+0.01 (+0.24%)
At close · Jul 22
Market Cap
$76.56M
Shares
18.54M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-06-17 | 2026-06-14 | |
| 8-K | 2026-06-05 | 2026-06-04 | |
| 8-K | 2026-05-29 | 2026-05-26 | |
| 8-K | 2026-05-07 | — | |
| 10-Q | 2026-05-07 | 2026-03-31 | |
| DEF 14A | 2026-04-24 | 2026-06-04 | |
| 10-K | 2026-02-13 | 2025-12-31 | |
| 8-K | 2026-02-11 | — | |
| 8-K | 2026-01-27 | — | |
| 8-K | 2026-01-12 | 2026-01-07 | |
| 10-Q | 2025-11-10 | 2025-09-30 | |
| 8-K | 2025-11-10 | — | |
| 10-Q | 2025-08-07 | 2025-06-30 | |
| 8-K | 2025-08-06 | — | |
| 8-K | 2025-06-03 | 2025-05-30 | |
| 8-K | 2025-05-14 | 2025-05-10 | |
| 10-Q | 2025-05-08 | 2025-03-31 | |
| 8-K | 2025-05-07 | — | |
| DEF 14A | 2025-04-11 | 2025-06-02 | |
| 8-K | 2025-03-20 | — | |
| 8-K | 2025-03-18 | — | |
| 8-K | 2025-03-11 | 2025-03-07 | |
| 8-K | 2025-03-06 | 2025-03-05 | |
| 10-K | 2025-02-28 | 2024-12-31 | |
| 8-K | 2025-02-26 | 2025-02-24 | |
| 8-K | 2025-02-19 | — | |
| DEF 14A | 2025-02-04 | 2025-03-05 | |
| 8-K | 2025-01-24 | 2025-01-23 | |
| 8-K | 2025-01-08 | 2025-01-07 | |
| 8-K | 2025-01-06 | 2025-01-03 | |
| 10-Q | 2024-11-07 | 2024-09-30 | |
| 8-K | 2024-11-06 | — | |
| 8-K | 2024-09-27 | 2024-09-23 | |
| 8-K | 2024-08-16 | 2024-08-15 | |
| 10-Q | 2024-08-08 | 2024-06-30 | |
| 8-K | 2024-08-07 | — | |
| 8-K | 2024-05-30 | 2024-05-29 | |
| 10-Q | 2024-05-09 | 2024-03-31 | |
| 8-K | 2024-05-08 | — | |
| 8-K | 2024-05-06 | — | |
| DEF 14A | 2024-04-11 | 2024-05-29 | |
| 8-K | 2024-03-13 | 2024-03-08 | |
| 8-K | 2024-02-21 | 2024-02-16 | |
| 10-K | 2024-02-21 | 2023-12-31 | |
| 8-K | 2024-01-08 | — | |
| 8-K | 2024-01-02 | — | |
| 8-K | 2023-12-11 | — | |
| 10-Q | 2023-11-08 | 2023-09-30 | |
| 8-K | 2023-11-07 | — | |
| 8-K | 2023-10-12 | — |
Showing 1–50 of 94 filings
Key facts
CIK
1484612
CUSIP
690145206
13F (30d)
13 filings
13 filers
Visit website
Investor relations